These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 29460131)
1. Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells. Wang Q; He WY; Zeng YZ; Hossain A; Gou X Int Urol Nephrol; 2018 Apr; 50(4):675-686. PubMed ID: 29460131 [TBL] [Abstract][Full Text] [Related]
2. FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy. Lin JZ; Wang WW; Hu TT; Zhu GY; Li LN; Zhang CY; Xu Z; Yu HB; Wu HF; Zhu JG Cancer Lett; 2020 Jan; 469():481-489. PubMed ID: 31738958 [TBL] [Abstract][Full Text] [Related]
3. Tea Polyphenol inhibits autophagy to sensitize Epirubicin-induced apoptosis in human bladder cancer cells. Gu W; Lin Y; Gou X; He W Neoplasma; 2017; 64(5):674-680. PubMed ID: 28592119 [TBL] [Abstract][Full Text] [Related]
4. [The mechanism underlying the effects of tea polyphenol on epirubicin-induced autophagy and apoptosis in T24 bladder cancer cells]. Gu W; Yin H; Liu Y; Gou X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jun; 33(6):772-777. PubMed ID: 28615100 [TBL] [Abstract][Full Text] [Related]
5. NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway. Luo S; Shao L; Chen Z; Hu D; Jiang L; Tang W Exp Cell Res; 2020 May; 390(2):111981. PubMed ID: 32234375 [TBL] [Abstract][Full Text] [Related]
6. Synergistic antitumor effect of NVP-BEZ235 and sunitinib on docetaxel-resistant human castration-resistant prostate cancer cells. Park HS; Hong SK; Oh MM; Yoon CY; Jeong SJ; Byun SS; Cheon J; Lee SE; Moon du G Anticancer Res; 2014 Jul; 34(7):3457-68. PubMed ID: 24982354 [TBL] [Abstract][Full Text] [Related]
8. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer. Chen Z; Jiang Q; Zhu P; Chen Y; Xie X; Du Z; Jiang L; Tang W Prostate; 2019 Jan; 79(1):44-53. PubMed ID: 30178500 [TBL] [Abstract][Full Text] [Related]
9. Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells. Gupta S; Weston A; Bearrs J; Thode T; Neiss A; Soldi R; Sharma S Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):349-357. PubMed ID: 27349498 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3. Hu F; Zhao Y; Yu Y; Fang JM; Cui R; Liu ZQ; Guo XL; Xu Q Cancer Lett; 2018 Mar; 416():24-30. PubMed ID: 29246644 [TBL] [Abstract][Full Text] [Related]
11. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy. Zeng J; Liu W; Fan YZ; He DL; Li L Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796 [No Abstract] [Full Text] [Related]
12. Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner. Wu F; Lin Y; Cui P; Li H; Zhang L; Sun Z; Huang S; Li S; Huang S; Zhao Q; Liu Q Cancer Chemother Pharmacol; 2018 Jun; 81(6):999-1006. PubMed ID: 29605876 [TBL] [Abstract][Full Text] [Related]
13. HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma. Pan B; Chen D; Huang J; Wang R; Feng B; Song H; Chen L Mol Cancer; 2014 Jul; 13():165. PubMed ID: 24996221 [TBL] [Abstract][Full Text] [Related]
14. Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer. Hongo H; Kosaka T; Oya M Cancer Sci; 2018 Sep; 109(9):2937-2945. PubMed ID: 29989268 [TBL] [Abstract][Full Text] [Related]
15. Dual Akt and Bcl-2 inhibition induces cell-type specific modulation of apoptotic and autophagic signaling in castration resistant prostate cancer cell lines. Avsar Abdik E; Abdik H; Turan D; Sahin F; Berger MR; Kaleagasioglu F Mol Biol Rep; 2021 Dec; 48(12):7755-7765. PubMed ID: 34647221 [TBL] [Abstract][Full Text] [Related]
16. Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells. Cristofani R; Montagnani Marelli M; Cicardi ME; Fontana F; Marzagalli M; Limonta P; Poletti A; Moretti RM Cell Death Dis; 2018 Aug; 9(9):889. PubMed ID: 30166521 [TBL] [Abstract][Full Text] [Related]
17. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Mhaidat NM; Zhang XD; Jiang CC; Hersey P Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842 [TBL] [Abstract][Full Text] [Related]
18. Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel. Yang Z; Chen JS; Wen JK; Gao HT; Zheng B; Qu CB; Liu KL; Zhang ML; Gu JF; Li JD; Zhang YP; Li W; Wang XL; Zhang Y J Exp Clin Cancer Res; 2017 Dec; 36(1):178. PubMed ID: 29216925 [TBL] [Abstract][Full Text] [Related]
19. KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy. Jia J; Zhang HB; Shi Q; Yang C; Ma JB; Jin B; Wang X; He D; Guo P Theranostics; 2019; 9(19):5464-5477. PubMed ID: 31534497 [TBL] [Abstract][Full Text] [Related]
20. EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1). Hour TC; Chung SD; Kang WY; Lin YC; Chuang SJ; Huang AM; Wu WJ; Huang SP; Huang CY; Pu YS Arch Toxicol; 2015 Apr; 89(4):591-605. PubMed ID: 24888374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]